193 related articles for article (PubMed ID: 20818341)
21. Stromal Lymphoid Response Status in Micropapillary Urothelial Carcinomas Diagnosed in Bladder Transurethral Resections and its Comparison with Conventional Urothelial Carcinomas.
HacihasanoĞlu E; YÜcetaŞ U; OkÇu O; BehzatoĞlu K
Turk Patoloji Derg; 2021; 37(1):26-31. PubMed ID: 32692402
[TBL] [Abstract][Full Text] [Related]
22. p-120 Catenin is a Useful Diagnostic Biomarker for Distinguishing Plasmacytoid and Sarcomatoid Variants From Conventional Urothelial Carcinoma.
Acosta AM; Barletta J; Sonpavde G; Schnitt S; Hirsch MS
Arch Pathol Lab Med; 2021 Aug; 145(8):1000-1008. PubMed ID: 33237989
[TBL] [Abstract][Full Text] [Related]
23. Micropapillary urothelial carcinoma: clinico-pathologic review.
Perepletchikov AM; Parwani AV
Pathol Res Pract; 2009; 205(12):807-10. PubMed ID: 19767154
[TBL] [Abstract][Full Text] [Related]
24. [Urothelial hyperplastic lesion with endophytic growth pattern: a clinicopathologic study].
Xiao L; Wang CF; Zhu XZ; Yin YL; Chen Y; Lu C; Yu B
Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):319-23. PubMed ID: 21756826
[TBL] [Abstract][Full Text] [Related]
25. Expression of epithelial-Mesenchymal transition related markers in Plasmacytoid Urothelial carcinoma of the urinary bladder.
Nomura S; Suzuki Y; Akatsuka J; Endo Y; Shimizu A; Hamasaki T; Kimura G; Kondo Y
BMC Urol; 2020 Jun; 20(1):72. PubMed ID: 32571273
[TBL] [Abstract][Full Text] [Related]
26. Tumor-associated neoexpression of the pS2 peptide and MUC5AC mucin in primary adenocarcinomas and signet ring cell carcinomas of the urinary bladder.
Kunze E; Krassenkova I; Fayyazi A
Histol Histopathol; 2008 May; 23(5):539-48. PubMed ID: 18283638
[TBL] [Abstract][Full Text] [Related]
27. Human epidermal growth factor receptor 2 expression in micropapillary urothelial carcinoma of the bladder: an analysis of 27 cases.
Goodman AL; Osunkoya AO
Hum Pathol; 2016 Nov; 57():160-164. PubMed ID: 27476777
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic utility of antibody to smoothelin in the distinction of muscularis propria from muscularis mucosae of the urinary bladder: a potential ancillary tool in the pathologic staging of invasive urothelial carcinoma.
Paner GP; Shen SS; Lapetino S; Venkataraman G; Barkan GA; Quek ML; Ro JY; Amin MB
Am J Surg Pathol; 2009 Jan; 33(1):91-8. PubMed ID: 18936687
[TBL] [Abstract][Full Text] [Related]
29. Plasmacytoid urothelial carcinoma of the bladder: histological and clinical features of 5 cases.
Fritsche HM; Burger M; Denzinger S; Legal W; Goebell PJ; Hartmann A
J Urol; 2008 Nov; 180(5):1923-7. PubMed ID: 18801525
[TBL] [Abstract][Full Text] [Related]
30. Mixed micropapillary and trophoblastic carcinoma of bladder: report of a first case with new immunohistochemical evidence of urothelial origin.
Regalado JJ
Hum Pathol; 2004 Mar; 35(3):382-4. PubMed ID: 15017598
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathologic analysis of patients undergoing repeat transurethral resection of bladder tumour following an initial diagnosis of urothelial carcinoma with lamina propria invasion and variant/divergent histology.
Mullane P; Joshi S; Bilen M; Osunkoya AO
J Clin Pathol; 2023 Apr; 76(4):256-260. PubMed ID: 34635538
[TBL] [Abstract][Full Text] [Related]
32. Urinary bladder urothelial carcinoma with expression of KIT and PDGFRA and showing diverse differentiations into plasmacytoid, clear cell, acantholytic, nested, and spindle variants, and into adenocarcinoma, signet-ring cell carcinoma, small cell carcinoma, large cell carcinoma, and pleomorphic carcinoma.
Terada T
Int J Clin Exp Pathol; 2013; 6(6):1150-6. PubMed ID: 23696935
[TBL] [Abstract][Full Text] [Related]
33. Differential expression of GATA-3 in urothelial carcinoma variants.
Liang Y; Heitzman J; Kamat AM; Dinney CP; Czerniak B; Guo CC
Hum Pathol; 2014 Jul; 45(7):1466-72. PubMed ID: 24745616
[TBL] [Abstract][Full Text] [Related]
34. The utility of p63, p40, and GATA-binding protein 3 immunohistochemistry in diagnosing micropapillary urothelial carcinoma.
Lin X; Zhu B; Villa C; Zhong M; Kundu S; Rohan SM; Yang XJ
Hum Pathol; 2014 Sep; 45(9):1824-9. PubMed ID: 24993315
[TBL] [Abstract][Full Text] [Related]
35. Micropapillary variant of transitional cell carcinoma of the urinary bladder. Histologic pattern resembling ovarian papillary serous carcinoma.
Amin MB; Ro JY; el-Sharkawy T; Lee KM; Troncoso P; Silva EG; Ordóñez NG; Ayala AG
Am J Surg Pathol; 1994 Dec; 18(12):1224-32. PubMed ID: 7977945
[TBL] [Abstract][Full Text] [Related]
36. E-cadherin expression in invasive urothelial carcinoma.
Sun W; Herrera GA
Ann Diagn Pathol; 2004 Feb; 8(1):17-22. PubMed ID: 15129905
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical Differentiation of Plasmacytoid Urothelial Carcinoma From Secondary Carcinoma Involvement of the Bladder.
Borhan WM; Cimino-Mathews AM; Montgomery EA; Epstein JI
Am J Surg Pathol; 2017 Nov; 41(11):1570-1575. PubMed ID: 28786878
[TBL] [Abstract][Full Text] [Related]
38. Plasmacytoid/diffuse urothelial carcinoma: a single-institution immunohistochemical and molecular study of 69 patients.
Perrino CM; Eble J; Kao CS; Whaley RD; Cheng L; Idrees M; Hashemi-Sadraei N; Monn MF; Kaimakliotis HZ; Bandali E; Grignon D
Hum Pathol; 2019 Aug; 90():27-36. PubMed ID: 31054897
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance of urothelial carcinoma ambiguous for muscularis propria invasion on initial transurethral resection of bladder tumor.
Hassan O; Murati Amador B; Lombardo KA; Salles D; Cuello F; Marwaha AS; Daniels MJ; Kates M; Bivalacqua TJ; Matoso A
World J Urol; 2020 Feb; 38(2):389-395. PubMed ID: 31030230
[TBL] [Abstract][Full Text] [Related]
40. E-cadherin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in rats.
Oliveira PA; Colaço A; De la Cruz LF; Lopes P; Lopes C
J Exp Clin Cancer Res; 2006 Sep; 25(3):425-32. PubMed ID: 17167984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
